Compare Moderna, Inc. (MRNA) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance

Moderna, Inc.Trade

State Street SPDR S&P Homebuilders ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs State Street SPDR S&P Homebuilders ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while State Street SPDR S&P Homebuilders ETF trades at $105.91. The key difference: Moderna, Inc. is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.

	MRNA	XHB
Market Cap	$23.60B	—
Sector	Health	Broad Market / Factor
52-Week High	$81.80	$121.36
52-Week Low	$22.36	$94.86
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

XHB

BlackRock Canada announces July 2026 monthly cash distributions for iShares ETFs.Blackrock Asset Management Canada Limited · 12 hours agoNeutral View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About State Street SPDR S&P Homebuilders ETF

XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.